Orly Savion
CEO

Alagene offers integrated biotechnology solutions that accelerate bioproduct development from computational design and cell engineering to precision fermentation and downstream processing. They leverage high-throughput screening and advanced genetic tools to optimize biological systems, enabling efficient scale-up and commercialization for biotech and pharmaceutical companies.
CEO
Developing novel biotechnological products and processes requires extensive expertise across multiple disciplines, from initial design and engineering to scalable production and regulatory compliance. This complexity can lead to extended R&D timelines and increased costs, hindering the efficient commercialization of innovative solutions.
Alagene provides integrated biotechnology solutions that streamline the entire product development lifecycle, from computational design and cell engineering to precision fermentation and downstream processing. The company leverages advanced molecular and genetic tools to optimize biological systems and employs high-throughput screening (HTS) and custom bio-assay development to accelerate strain and condition identification. Alagene's expertise in precision fermentation process design ensures scalability and efficiency for various bioproducts, while their downstream processing capabilities focus on maximizing yield and purity. Additionally, Alagene offers product and business strategy consulting to guide clients through market entry and regulatory landscapes.
Alagene serves biotechnology companies, pharmaceutical developers, and research institutions seeking to accelerate R&D, optimize bioprocesses, and navigate the complexities of product commercialization.